Our clinical research aims at studying the angiogenic factors, in particular, the PlGF, bFGF, and VEGF—their expressions in the SLE patients, their interrelationships, and their correlations with other clinical indicators, by which investigating the role of AF in the pathogenesis of SLE. Here, FGF2 is linked to systemic lupus erythematosus.